Delivery Order SPE2DB22D2009-SPE2DB24FL8HD
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with the prime contractor, Amerisourcebergen Drug Corp, is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $10,470.61 and is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The $9,604.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a completion date of May 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,624.51 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award provides for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $4,369.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 11, 2024 with an ultimate completion date of July 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,408.29 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The award has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Advair HFA 115-21 MCG inhalers. The $6,390.24 order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers for the Defense Logistics Agency (DLA). The contract, valued at $2,672.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of February 5, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Advair HFA 115-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $7,158.70 and a performance period through March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL8HDDelivery Order
This federal contract award is for the delivery of Advair HFA 115-21 mcg inhalers to the Defense Logistics Agency (DLA). The contract, valued at $6,595.62, was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The current award is a firm fixed price delivery order issued under this IDC. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 2/20/24 |